Completed NA INTERVENTIONAL 2-arm NCT03856502

Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures

Impact of Intrathecal Dexamethasone Administration for Elderly Patients With Proximal Femoral Fracture

Sponsor: General Hospital Sveti Duh

Conditions Cognition Disorders Cortisol; Hypersecretion Femoral Fracture

Interventions 12,5 mg of 0,5 % of levobupivacaine 8 mg of dexamethasone

Updated 4 times since 2019 Last updated: Feb 26, 2019 Started: Nov 11, 2012 Primary completion: May 26, 2016 Completion: Jul 4, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03856502, this NA trial focuses on Cognition Disorders and Cortisol; Hypersecretion and remains completed. Sponsored by General Hospital Sveti Duh, it has been updated 4 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2019 — Jan 2021 [monthly]

Completed NA

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital Sveti Duh

Data source: General Hospital Sveti Duh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zagreb, Croatia